News & Announcements
Assistant Dean at Temple University School of Medicine Selected One of Region's Most Influential Latinos
Raul A. DeLa Cadena, MD, Assistant Dean and Director of the Recruitment, Admissions and Retention (RAR) Program at Temple University School of Medicine, has been selected as one of the "Delaware Valley's Most Influential Latinos" for 2012. He was selected for the honor by the Most Influential Latinos Foundation, whose stated mission is to support and encourage Latino leadership and empowerment. Dr. DeLa Cadena will be recognized, along with the other honorees, at a Gala Dinner and celebration on November 29 in Philadelphia.
"This is a great honor for which I am pleased to be recognized," said Dr. DeLa Cadena. "It is also a reflection on Temple University School of Medicine's proud legacy of helping disadvantaged students overcome academic and economic obstacles that contribute to their underrepresentation among our nation's physicians."
As Director of Temple's RAR Program, Dr. DeLa Cadena works to enhance the recruitment of underrepresented minorities to the School of Medicine. The primary purpose of the RAR Program is to help Temple identify, enroll, retain and graduate physicians from such backgrounds to infuse diversity into the healthcare workforce in the profession of medicine both regionally and nationally.
"This selection of Dr. DeLa Cadena as one of the region's most influential Latinos is well deserved," said Arthur M. Feldman, MD, PhD, Executive Dean of Temple University School of Medicine. "Dr. DeLa Cadena works tirelessly to help Temple actualize its commitment to diversity in its student body, while also maintaining excellence in its academic programs."
Dr. DeLa Cadena also serves as Professor of Physiology and holds a faculty appointment at Temple's Sol Sherry Thrombosis Research Center. His research focuses on the pathophysiology of Diabetic Retinopathy and Rheumatoid Arthritis.
Date Published: Wednesday, November 21, 2012
back | view all news
Temple Research Finds that Minimally-Invasive, Catheter-Based Clot Removal Does Not Increase Death Rate for Patients with Leg Clots
Temple research examines the safety of treatments for deep vein thrombosis.
read more »
Cherie P. Erkmen, MD, Named Director of Lung Cancer Screening Program at Temple University Hospital
Cherie P. Erkmen, MD, has been appointed Director of the Lung Cancer Screening Program at Temple University Hospital, and Associate Professor of Surgery at Temple University School of Medicine.
read more »
Temple University Researchers Successfully Eliminate the HIV Virus from Cultured Human Cells for the First Time
The HIV-1 virus has proved to be tenacious, inserting its genome permanently into its victims' DNA, forcing patients to take a lifelong drug regimen to control the virus and prevent a fresh attack. Now, a team of Temple University School of Medicine researchers has designed a way to snip out the integrated HIV-1 genes for good.
read more »